2m 2m 2m 2m 2m 2m 2m
QUOIN PHARMA SP ADS (QNRX)
NASDAQ
$4.40-$0.16 (-3.51%)
Price as of Jun 03, 2026 5:01 PM EDT- $10.2MMarket Cap
- -49.16%1-Year Change
- BiotechnologyIndustry
QUOIN PHARMA SP ADS (QNRX)
$4.40-$0.16 (-3.51%)
QNRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.56 | ||
Change | -$0.21 (-4.40%) | ||
Open | $4.83 | ||
High | $5.09 | ||
Low | $4.56 | ||
Previous Close | $4.77 | ||
Volume | 31,025 | ||
30-Day Average Volume | 27,480 | ||
1-Week Change | -5.79% | ||
1-Month Change | -26.57% | ||
1-Year Change | -49.16% | ||
3-Year Change | -97.64% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 2.0M | ||
Total Assets | $15.7M | ||
Market Cap | $10.2M | ||
Enterprise Value | $7.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.0M | ||
Free Cash Flow | -$4.9M | ||
EBIT | -$5.0M | ||
EBITDA | -$5.0M | ||
Net Working Capital | $10.0M | ||
EPS | -$1.77 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 2 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 35 | ||
Last Split Date | 04/09/2025 | ||
Earnings & Revenue